Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Consalvo Mattia

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Current Pharmaceutical Design|September 24, 2005
Coping with neuropathic pain: do we need more selective analgesic drugs?Consalvo Mattia
Current Pharmaceutical Design|July 4, 2012
Editorial: non-analgesic effects of opioids: the dark side of the moonConsalvo Mattia
Therapeutics and Clinical Risk Management|March 25, 2008
Acute postoperative pain management: focus on iontophoretic transdermal fentanylConsalvo Mattia, Flaminia Coluzzi
Therapeutics and Clinical Risk Management|May 3, 2014
Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plasterRoberto Casale, Consalvo Mattia
Current Pharmaceutical Design|September 24, 2005
Mechanism-based treatment in chronic neuropathic pain: the role of antidepressantsFlaminia Coluzzi, Consalvo Mattia
Mini Reviews in Medicinal Chemistry|October 8, 2003
Antidepressants in chronic neuropathic painConsalvo Mattia, Flaminia Coluzzi
Expert Opinion on Pharmacotherapy|August 24, 2006
Once-daily tramadol in rheumatological painConsalvo Mattia, Flaminia Coluzzi
Idrugs : the Investigational Drugs Journal|September 6, 2007
Indantadol, a novel NMDA antagonist and nonselective MAO inhibitor for the potential treatment of neuropathic painConsalvo Mattia, Flaminia Coluzzi
Future Oncology (London, England)|May 18, 2016
Management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day highly or moderately emetogenic chemotherapy: role of transdermal granisetronFlaminia Coluzzi, Consalvo Mattia
Therapeutics and Clinical Risk Management|May 14, 2008
Chronic non-cancer pain: Focus on once-daily tramadol formulationsFlaminia Coluzzi, Consalvo Mattia
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|September 24, 2005
Coping with neuropathic pain: do we need more selective analgesic drugs?Consalvo Mattia
Current Pharmaceutical Design|July 4, 2012
Editorial: non-analgesic effects of opioids: the dark side of the moonConsalvo Mattia
Therapeutics and Clinical Risk Management|March 25, 2008
Acute postoperative pain management: focus on iontophoretic transdermal fentanylConsalvo Mattia, Flaminia Coluzzi
Therapeutics and Clinical Risk Management|May 3, 2014
Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plasterRoberto Casale, Consalvo Mattia
Current Pharmaceutical Design|September 24, 2005
Mechanism-based treatment in chronic neuropathic pain: the role of antidepressantsFlaminia Coluzzi, Consalvo Mattia
Mini Reviews in Medicinal Chemistry|October 8, 2003
Antidepressants in chronic neuropathic painConsalvo Mattia, Flaminia Coluzzi
Expert Opinion on Pharmacotherapy|August 24, 2006
Once-daily tramadol in rheumatological painConsalvo Mattia, Flaminia Coluzzi
Idrugs : the Investigational Drugs Journal|September 6, 2007
Indantadol, a novel NMDA antagonist and nonselective MAO inhibitor for the potential treatment of neuropathic painConsalvo Mattia, Flaminia Coluzzi
Future Oncology (London, England)|May 18, 2016
Management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day highly or moderately emetogenic chemotherapy: role of transdermal granisetronFlaminia Coluzzi, Consalvo Mattia
Therapeutics and Clinical Risk Management|May 14, 2008
Chronic non-cancer pain: Focus on once-daily tramadol formulationsFlaminia Coluzzi, Consalvo Mattia
Pageof 4